Teva Pharma Appoints Eli Kalif To Succeed Michael McClellan As CFO - Quick Facts

(RTTNews) - Israeli generic medicines producer Teva Pharmaceutical Industries Ltd. (TEVA) announced Thursday the appointment of Eli Kalif as Executive Vice President and Chief Financial Officer, effective December 22, 2019. Kalif will be based out of Teva's global headquarters in Israel.

Kalif joins Teva with broad experience in corporate and operational finance, most recently as Senior Vice President, Finance, leading the finance organization that supports the Global Operations, Components & services business at Flex Ltd. (FLEX).

"Eli brings to Teva more than 20 years of leadership roles with a proven track record in complex financial organizations, where he was responsible for leading global teams supporting multi-billion-dollar operations within a dynamic market environment," said Kre Schultz, Teva's President and CEO.

Schultz will perform the functions of CFO from the date of Michael McClellan's departure on November 8, 2019 until Kalif begins employment with the Company on December 22, 2019.

In early August, the company announced that McClellan has decided to step down from his role as CFO due to personal reasons requiring him to be located near his family.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Latest Markets Videos


    Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

    Learn More